Market Update: Extended Trading Insights
In the latest after-hours trading session, several prominent companies released their quarterly earnings, resulting in varied market responses. Here’s a closer look at the key players making headlines:
Palantir Technologies
Shares of Palantir fell nearly 7% following the release of its first-quarter earnings, which matched Wall Street’s expectations. The defense technology firm reported adjusted earnings of 13 cents per share and revenue of $884 million, surpassing the $863 million forecast by analysts.
Vertex Pharmaceuticals
Vertex saw a decline of 2% after disappointing quarterly results. The biotech company reported adjusted earnings of $4.06 per share, falling short of the $4.32 estimate. Additionally, its revenue of $2.77 billion did not meet the anticipated $2.85 billion.
Mattel
Toymaker Mattel experienced a 2.5% drop in shares as it paused its full-year guidance for 2025 due to uncertainties surrounding tariffs. Despite this, the company reported first-quarter results that exceeded expectations.
Neurocrine Biosciences
In contrast, Neurocrine Biosciences saw a significant boost, with shares up 11% in post-market trading. The company’s first-quarter revenue reached $572.6 million, exceeding the $559.6 million estimate. Sales of its popular drug Ingrezza increased by 8% year over year.
Lattice Semiconductor
Lattice Semiconductor shares fell 3.8% after first-quarter earnings and revenue matched consensus estimates. The company provided a revenue guidance of $118.5 million to $128.5 million, slightly below analyst expectations of $123.6 million.
Hims & Hers Health
Hims & Hers reported a 1% decline, as its second-quarter revenue guidance fell short of expectations. The company projected revenue between $530 million and $550 million, below the $564.6 million analysts anticipated.
Ford Motor Company
Ford’s shares decreased by 2.7% after the company revealed significant earnings drops in the first quarter. EBIT plunged to $1.02 billion from $2.76 billion a year earlier, prompting the automaker to withdraw its forward guidance due to anticipated tariff impacts.
Clorox
Clorox also saw a decline of 2.8%, with adjusted earnings of $1.45 per share and revenue of $1.67 billion. Both figures fell short of analyst expectations of $1.57 per share and $1.73 billion, respectively.
Diamondback Energy
In a positive turn, Diamondback Energy’s stock advanced by nearly 1% after reporting stronger-than-expected results. The company earned $4.54 per share for the first quarter, exceeding the FactSet estimate of $4.18, while its capital expenditures were lower than forecasted.
As these companies navigate through their financial results amidst a challenging economic landscape, investors will be closely monitoring their performance in the upcoming quarters. The mixed reactions highlight the ongoing volatility and diverse challenges within different sectors of the economy.
